Clinical trial
Effect of Probiotic Co-administration With Omega-3 Fatty Acids on Obesity Parameters and Insulin Resistance
NCT04201938
Study timeline
Study start (actual)2018-02-01Date precision: day
Registry last updated2023-06-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Obesityunresolved
Insulin Resistanceunresolved
Insulin Sensitivityunresolved
Type2 Diabetesunresolved
Visceral Obesityunresolved
Interventions
Symbiter-OmegaCOMBINATION_PRODUCT
PlaceboDIETARY_SUPPLEMENT
Sponsors & collaborators
Bogomolets National Medical Universitylead sponsor
Taras Shevchenko National University of Kyivcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04201938 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.